Literature DB >> 17962875

Epidemiological and microbiological analysis of ventilator-associated pneumonia patients in a public teaching hospital.

João Manoel da Silva1, Ederlon Rezende, Thaís Guimarães, Edvaldo V dos Campos, Luiz André Magno, Lívia Consorti, Renata Andréa Pietro Pereira, Maria de Lourdes Nascimento, João Silva de Mendonça.   

Abstract

Ventilator-associated pneumonia (VAP) is the most commonly-acquired infection in patients in intensive care units. We analyzed epidemiological and microbiological characteristics and the outcome, in a cohort of critically-ill patients with confirmed diagnosis of VAP. All patients who had been on mechanical ventilation (MV) for more than 48 hours were included in our study; material collection for microbiological analysis was done within the first 24 hours after beginning treatment or after changing antibiotics. There were 55/265 (20.7%) VAP cases diagnosed, at a rate of 21.6 episodes per 1,000 days of mechanical ventilation. Mean age of the patients was 66 years, with a mean APACHE II score of 26.7 + 7.0; male patients were more prevalent. The mortality rates in the intensive care unit (ICU) and during the hospital stay were 71% and 80%, respectively. MV duration in patients with VAP was 17 (range 3-43) days and among patients who had not developed VAP, 6 (2-32) days (p < 0.0001). 98.2% of the samples were positive, with a high prevalence of Gram-negative bacteria, mainly Acinetobacter calcoaceticus. Risk factors for death included age, MV duration and surgery. VAP incidence in this sample of critically-ill patients was high, with a high mortality rate. Control and prevention strategies based on continuing education of healthcare workers, developed by a multidisciplinary team, should be encouraged to minimize morbimortality of this infection.

Entities:  

Mesh:

Year:  2007        PMID: 17962875     DOI: 10.1590/s1413-86702007000500009

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  7 in total

1.  Risk factors for acquisition of ventilator-associated pneumonia in adult intensive care units.

Authors:  Fariba Lahoorpour; Ali Delpisheh; Abdorrahim Afkhamzadeh
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

2.  Infection rate and risk factors associated with infections related to external ventricular drain.

Authors:  E F Camacho; I Boszczowski; M Basso; B C P Jeng; M P Freire; T Guimarães; M J Teixeira; S F Costa
Journal:  Infection       Date:  2011-01-25       Impact factor: 3.553

3.  Effect of Ondansetron on Prevention of Ventilator Associated Pneumonia in Intensive Care Unit Patients in Kashani Hospital in 2013.

Authors:  Hossein Madineh; Omolbanin Rahimi; Mohamadreza Abedin Zadeh; Majid Kabiri
Journal:  J Clin Diagn Res       Date:  2017-08-01

4.  Is it necessary to have a dentist within an intensive care unit team? Report of a randomised clinical trial.

Authors:  Wanessa Teixeira Bellissimo-Rodrigues; Mayra Gonçalves Menegueti; Gilberto Gambero Gaspar; Hayala Cristina Cavenague de Souza; Maria Auxiliadora-Martins; Anibal Basile-Filho; Roberto Martinez; Fernando Bellissimo-Rodrigues
Journal:  Int Dent J       Date:  2018-05-18       Impact factor: 2.607

5.  Precalcitonin and C-reactive protein as markers in response to antibiotic treatment in ventilator-associated pneumonia in intensive care unit-hospitalized patients.

Authors:  Babak Ali Kiaei; Farzin Ghiasi; Daryoush Moradi
Journal:  Adv Biomed Res       Date:  2015-10-29

6.  Investigating PIK3R3 and ATp2A1 Genes Expressions in Ventilator-Associated Pneumonia Patients Admitted to the Intensive Care Unit of Masih Daneshvari Hospital in 2016.

Authors:  Hamidreza Jamaati; Naghmeh Bahrami; Mahya Daustany; Payam Tabarsi; Behrooz Farzanegan; Seyed Mohammadreza Hashemian; Abdolreza Mohamadnia
Journal:  Rep Biochem Mol Biol       Date:  2018-04

7.  Epidemiology and outcomes of ventilator-associated pneumonia in northern Brazil: an analytical descriptive prospective cohort study.

Authors:  Marília M Resende; Sílvio G Monteiro; Bianca Callegari; Patrícia M S Figueiredo; Cinara R A V Monteiro; Valério Monteiro-Neto
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.